Physician profile
Brent Porter
NPI 1588680672
$1,120.37
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,104 · 2022: $16.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $247.46 | 2019 | |
| Glaxosmithkline, LLC. | $205.52 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $193.02 | 2019 | |
| Sanofi-Aventis U.S. LLC | $115.13 | 2019 | |
| Janssen Pharmaceuticals, INC | $87.76 | 2019 | |
| Astellas Pharma US INC | $60.65 | 2019 | |
| Radius Health, INC. | $52.40 | 2019 | |
| Pfizer INC. | $50.88 | 2019 | |
| Lilly USA, LLC | $21.13 | 2019 | |
| Akcea Therapeutics, INC. | $18.82 | 2019 | |
| Circassia INC. | $15.09 | 2019 | |
| Allergan, INC. | $14.58 | 2019 | |
| Mannkind Corporation | $13.86 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.38 | 2019 | |
| Merck Sharp & Dohme LLC | $11.69 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Porter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.